ArticleAmerican journal of translational research2026
Effectiveness of orthokeratology plus vision therapy for controlling myopia progression in children.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAddressing myopia in children, this study analyzed the effectiveness of orthokeratology (Ortho-K) plus vision therapy (VT) for controlling myopia progression.
methodsThe study population was composed of 155 myopia-affected children (August 2022-August 2025), who were assigned to the ortho-K group (n=75) wearing Ortho-K lenses and the Ortho-K+VT group (n=80) that was additionally given VT intervention. Inter-group comparative assessments were then conducted from the perspectives of clinical effectiveness, visual acuity (VA) measures (best-corrected VA, uncorrected VA), refractive structural parameters (axial length, spherical equivalent), corneal parameters (central corneal thickness, mean keratometry), accommodation parameters (accommodation amplitude, accommodative facility, accommodative response), accommodation-convergence synergy parameters (positive/negative relative accommodation, accommodative convergence/accommodation ratio), complications (corneal epithelial punctate staining, conjunctival congestion, dry eye symptoms, papillary conjunctivitis), and vision-related quality of life (25-Item National Eye Institute Visual Function Questionnaire).
resultsThe total effective rate was significantly higher in the Ortho-K+VT group than in the Ortho-K group. After the intervention, all VA measures, refractive structure parameters, corneal parameters, accommodation parameters, accommodation-convergence synergy parameters, and vision-related quality of life were significantly better in patients receiving Ortho-K+VT. The total complication rate was significantly lower in the Ortho-K+VT group than in the Ortho-K group.
conclusionOrtho-K combined with VT was effective in controlling myopia progression in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.